 |
|
|
|
|
|
|
|
 |
 |
 |
|
||||
 |
 |
 |
 |
 |
|
||
 |
|
||||||
 |
|
||||||
 |
|
||||||
 |
|
||||||
 |
 |
|
|||||
 |
 |
|
|||||
 |
 |
 |
|
||||
原料药&中间体 |
|
原料药 API's (Active Pharmaceutical Ingredient's)
|
| 免疫抑制剂类 | |||
| 环孢菌素 A, Cyclosporin A | 59865-13-3 | 环孢菌素 H, Cyclosporin H | 83602-39-5 |
| 环孢菌素 D, Cyclosporin D | 63775-96-2 | 雷帕霉素, Sirolimus (Rapamycin) | 53123-88-9 |
| 环孢菌素 C, Cyclosporin C | 59787-61-0 | 他克莫司, Tacrolimus (FK506) | 104987-11-3 |
| 麦考酚酸, Mycophenolic acid | 24280-93-1 | 麦考酚酸酯, Mycophenolate mofetil [115007-34-6] | 128794-94-5 |
| 抗帕金森 | |||
| 普拉克索, Pramipexole dihydrochloride | 104632-26-0 | 罗匹尼罗, Ropinirole hydrochloride | 91374-21-9 |
| 抗病毒和抗艾滋 | |||
| 替诺褔韦, Tenofovir disoproxil fumarate | 202138-50-9 | 恩曲他滨, Emtricitabine | 143491-57-0 |
| 抗癌药 | |||
| 甲磺酸伊马替尼, Imatinib mesylate | 220127-57-1 | 伊马替尼碱, Imatinib base | 152459-95-5 |
| 马来酸舒尼替尼, Sunitinib malate | 341031-54-7 | 舒尼替尼碱, Sunitinib base | 152459-95-5 |
| 琥珀酸瓦他拉尼, Vatalanib succinate | 212142-18-2 | 瓦他拉尼碱, Vatalanib base | 212141-54-3 |
| 盐酸埃罗替尼, Erlotinib hydrochloride | 183319-69-9 | 埃罗替尼碱, Erlotinib base | 183321-74-6 |
| 二甲苯磺酸拉帕替尼, Lapatinib Ditosylate | 388082-78-8 | 拉帕替尼碱, Lapatinib base | 231277-92-2 |
| 吉非替尼, Gefitinib | 184475-35-2 | 尼罗替尼, Nilotinib | 641571-10-0 |
| 喹喏酮类抗菌药 | |||
| 左旋氧氟沙星半水物, Levofloxacin hemihydrate | 100986-85-4 | 盐酸洛美沙星, Lomefloxacin hydrochloride | 98079-51-7 |
| 其他原料药 | |||
| 氢溴酸槟榔碱, Arecoline hydrobromide | 300-08-3 | 盐酸度洛西汀, Duloxetine hydrochloride | 136434-34-9 |
| 盐酸丙美卡因, Proxymetacaine hydrochloride | 5875-06-9 | 齐留通, Zileuton | 111406-87-2 |
| 氟阿尼酮 Fluanisone | 1480-19-9 | 美海屈林萘二磺酸盐, Mebhydrolin napadisylate | 6153-33-9 |
| 饲料添加剂及兽药 | |||
| 盐酸莱克多巴胺, Ractopamine hydrochloride | 90274-24-1 | 盐酸齐帕特罗, Zilpaterol hydrohloride | 119520-06-8 |
| 布帕伐醌, Buparvaquone | 88426-33-9 | ||
None of the products will be supplied to countries in which this could be in conflict with the existing patents. However the final responsibility lies with the Buyer. 这些产品将不供应任何有专利保护的地区和国家，由此引起的法律责任及一切后果将由采购方承担。 中间体 Intermediates
|
| 甲磺酸伊马替尼 Imatinib mesylate [220127-57-1] 4-[(4-Methyl-1-piperazinyl)methyl]benzoic acid dihydrochloride hemihydrate Cas number: 106261-49-8 N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine Cas number: 152460-10-1 N-(5-Nitro-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidineamine Cas number: 152460-09-8 2-Dimethylamino-1-(3-pyridyl)-2-propene-1-one Cas: 55314-16-4 2-Methyl-5-nitro phenyl guanidine nitrate Cas number: 152460-08-7, (152460-07-6 for free base) 马来酸舒尼替尼 Sunitinib Malate [341031-54-7] 1-chloro-4-(4-pyridylmethyl)phthalazine [101094-85-3] 906531-30-4 for HCl salt, 906531-29-1 for DiHCl salt 埃罗替尼 Erlotinib [183319-69-9] 6,7-bis-(2-Methoxyethoxy)-quinazolin-4(3h)-one [179688-29-0] 4-Chloro-6,7-(2-methoxyethoxy)-quinazoline [183322-18-1] 尼罗替尼 Nilotinib [641571-10-0] 3-[(Aminoiminomethyl)amino]-4-methyl-benzoic acid ethyl ester mononitrate 4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid ethyl ester 4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid |
拉帕替尼 Lapatinib [231277-92-2] |